Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for the Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices MSN/2023/088 Tier 2 – medium impact Date of issue 21st September 2023 Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices are being discontinued and stock will [...]

The post Medicine Supply Notification: Discontinuation of lixisenatide (Lyxumia® ) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Scopoderm®) 1.5mg patches. MSN/2023/087 Tier 2 – medium impact Date of issue 21st September 2023 Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January 2024. Alternative formulations of hyoscine hydrobromide remain available and will be [...]

The post Medicine Supply Notification: Hyoscine hydrobromide (Scopoderm® ) 1.5mg patches appeared first on Community Pharmacy England.

Drug alert number: EL (23)A/36 Date issued: 20 September 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trimbow 87/5/9 mcg pressurised inhalation solution PLGB 08829/0193 SNOMED Code: 34681611000001100 Batch Number Expiry Date Pack Size First Distributed 1165031 18/09/2024 1 container with 120 actuations 19/01/2023 1150215 25/12/2023 [...]

The post MHRA Class 3 Medicines Recall: Trimbow 87/5/9 mcg pressurised inhalation solution (Chiesi Ltd) appeared first on Community Pharmacy England.

Pharmacy press We were asked to respond to suggestions that the Independent Prescribing (IP) Pathfinder Programme has been under-funded and pharmacies which had previously expressed interest are pulling out as a result. Our Director of NHS Services, Alastair Buxton, said: “The proposed funding and other aspects of the IP pathfinder programme has raised concerns for [...]

The post Fee for independent prescribing under pathfinder programme appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/09/2023) announced the following initial list of price concessions for September 2023: Drug Pack size Price concession Acamprosate 333mg gastro-resistant tablets 168 £23.67 Aciclovir 800mg tablets 35 £3.81 [...]

The post September 2023 Price Concessions 1st Update appeared first on Community Pharmacy England.